<VariationArchive VariationID="203629" VariationName="NM_000048.4(ASL):c.1045_1057del (p.Val349fs)" VariationType="Deletion" Accession="VCV000203629" Version="15" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-17" DateCreated="2017-01-07" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="200158" VariationID="203629">
      <GeneList>
        <Gene Symbol="ASL" FullName="argininosuccinate lyase" GeneID="435" HGNC_ID="HGNC:746" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="66075819" stop="66093576" display_start="66075819" display_stop="66093576" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="65540775" stop="65558329" display_start="65540775" display_stop="65558329" Strand="+" />
          </Location>
          <OMIM>608310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000048.4(ASL):c.1045_1057del (p.Val349fs)</Name>
      <CanonicalSPDI>NC_000007.14:66089675:GCGTCATCTCTACGC:GC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="66089676" stop="66089688" display_start="66089676" display_stop="66089688" variantLength="13" positionVCF="66089675" referenceAlleleVCF="GGCGTCATCTCTAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="65554663" stop="65554675" display_start="65554663" display_stop="65554675" variantLength="13" positionVCF="65554662" referenceAlleleVCF="GGCGTCATCTCTAC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V329fs</ProteinChange>
      <ProteinChange>V349fs</ProteinChange>
      <ProteinChange>V323fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.65554665_65554677del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.65554665_65554677del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.66089678_66089690del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.66089678_66089690del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009288.1" sequenceAccession="NG_009288" sequenceVersion="1" change="g.18890_18902del">
            <Expression>NG_009288.1:g.18890_18902del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000048.4" sequenceAccession="NM_000048" sequenceVersion="4" change="c.1045_1057del" MANESelect="true">
            <Expression>NM_000048.4:c.1045_1057del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000039.2" sequenceAccession="NP_000039" sequenceVersion="2" change="p.Val349fs">
            <Expression>NP_000039.2:p.Val349fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024943.2" sequenceAccession="NM_001024943" sequenceVersion="2" change="c.1045_1057del">
            <Expression>NM_001024943.2:c.1045_1057del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001020114.1" sequenceAccession="NP_001020114" sequenceVersion="1" change="p.Val349fs">
            <Expression>NP_001020114.1:p.Val349fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024944.2" sequenceAccession="NM_001024944" sequenceVersion="2" change="c.985_997del">
            <Expression>NM_001024944.2:c.985_997del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001020115.1" sequenceAccession="NP_001020115" sequenceVersion="1" change="p.Val329fs">
            <Expression>NP_001020115.1:p.Val329fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024946.2" sequenceAccession="NM_001024946" sequenceVersion="2" change="c.967_979del">
            <Expression>NM_001024946.2:c.967_979del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001020117.1" sequenceAccession="NP_001020117" sequenceVersion="1" change="p.Val323fs">
            <Expression>NP_001020117.1:p.Val323fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000048.3" sequenceAccession="NM_000048" sequenceVersion="3" change="c.1045_1057delGTCATCTCTACGC">
            <Expression>NM_000048.3:c.1045_1057delGTCATCTCTACGC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000048.3" sequenceAccession="NM_000048" sequenceVersion="3" change="c.1045_1057del13">
            <Expression>NM_000048.3:c.1045_1057del13</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA312349" DB="ClinGen" />
        <XRef Type="rs" ID="796051933" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000048.4(ASL):c.1045_1057del (p.Val349fs) AND not provided" Accession="RCV000185780" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000048.4(ASL):c.1045_1057del (p.Val349fs) AND Argininosuccinate lyase deficiency" Accession="RCV000668476" Version="10">
        <ClassifiedConditionList TraitSetID="605">
          <ClassifiedCondition DB="MedGen" ID="C0268547">Argininosuccinate lyase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-03" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000048.4(ASL):c.1045_1057del (p.Val349fs) AND Neurodevelopmental disorder" Accession="RCV001375026" Version="2">
        <ClassifiedConditionList TraitSetID="37229">
          <ClassifiedCondition DB="MedGen" ID="C1535926">Neurodevelopmental disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-03" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2017-01-07" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12384776</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16941645</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1705937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21710918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24166829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31943503</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9045711</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="605" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="326" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic Aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arginino succinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inborn error of urea synthesis, arginino succinic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Urea cycle disorder, arginino succinase type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Argininosuccinate lyase deficiency</ElementValue>
                <XRef ID="Argininosuccinic+Aciduria/576" DB="Genetic Alliance" />
                <XRef ID="41013004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASL deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinate acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic acid lyase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5843" />
                <XRef ID="5843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of argininosuccinate lyase (ASL), the enzyme that cleaves argininosuccinic acid to produce arginine and fumarate in the fourth step of the urea cycle, may present as a severe neonatal-onset form or a late-onset form: The severe neonatal-onset form is characterized by hyperammonemia within the first few days after birth that can manifest as increasing lethargy, somnolence, refusal to feed, vomiting, tachypnea, and respiratory alkalosis. Absence of treatment leads to worsening lethargy, seizures, coma, and even death. In contrast, the manifestations of late-onset form range from episodic hyperammonemia triggered by acute infection or stress to cognitive impairment, behavioral abnormalities, and/or learning disabilities in the absence of any documented episodes of hyperammonemia. Manifestations of ASL deficiency that appear to be unrelated to the severity or duration of hyperammonemic episodes: Neurocognitive deficiencies (attention-deficit/hyperactivity disorder, developmental delay, seizures, and learning disability). Liver disease (hepatitis, cirrhosis). Trichorrhexis nodosa (coarse brittle hair that breaks easily). Systemic hypertension.</Attribute>
                <XRef ID="NBK51784" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21290785</ID>
                <ID Source="BookShelf">NBK51784</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Argininosuccinic-Acidemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Argininosuccinic Acidemia, [Urea Cycle Disorder], 2012</CitationText>
              </Citation>
              <XRef ID="23" DB="Orphanet" />
              <XRef ID="C0268547" DB="MedGen" />
              <XRef ID="MONDO:0008815" DB="MONDO" />
              <XRef Type="MIM" ID="207900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0025630" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38088" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder</ElementValue>
                <XRef ID="MONDO:0700092" DB="MONDO" />
              </Name>
              <XRef ID="C1535926" DB="MedGen" />
              <XRef ID="D065886" DB="MeSH" />
              <XRef ID="MONDO:0700092" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7823169" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_000048.4:c.1045_1057del|OMIM:207900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004183478" DateUpdated="2024-06-17" DateCreated="2023-12-24" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000048.4:c.1045_1057del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="207900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB14009324</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1543389" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="21205|OMIM:207900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000793086" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24166829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1705937</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="G" referenceAllele="GGCGTCATCTCTAC" start="65554662" stop="65554675" variantLength="14" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001024943.1:c.1045_1057del13</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="207900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3418135" SubmissionDate="2021-06-17" DateLastUpdated="2021-06-23" DateCreated="2021-06-23">
        <ClinVarSubmissionID localKey="NM_000048.3:c.1045_1057del13|MedGen:C0268547" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737746" DateUpdated="2021-06-23" DateCreated="2021-06-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24166829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12384776</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31943503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1705937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21710918</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9045711</ID>
          </Citation>
          <Comment>Variant summary: ASL c.1045_1057del13 (p.Val349CysfsX72) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 3.6e-05 in 250612 control chromosomes (gnomAD). c.1045_1057del13 has been reported in the literature in multiple individuals affected with Argininosuccinic Aciduria (Barbosa_1991, Walker_1997, Beck_2011, Balmer_2014, Zielonka_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports this deletion apparently causes exon skipping (Barbosa_1991). Four submitters (evaluation after 2014) cite the variant as pathogenic (n=3) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000048.3:c.1045_1057del13</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268547" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9873253</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="441863" SubmissionDate="2022-03-30" DateLastUpdated="2023-03-04" DateCreated="2015-07-18">
        <ClinVarSubmissionID localKey="GDXSV:223874" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000238713" DateUpdated="2023-03-04" DateCreated="2015-07-18" Type="SCV" Version="9" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Gel-based analysis of mRNA derived from patient fibroblast cells harboring c.1045_1057del found that this variant frequently results in exon skipping (Barbosa et al. 1991); Frameshift variant predicted to result in protein truncation, as the last 116 amino acids are replaced with 71 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9045711, 21710918, 31943503, 1705937)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4521</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000048.3:c.1045_1057del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_73_20211201054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_98_20220330054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3094865" SubmissionDate="2023-11-06" DateLastUpdated="2023-11-11" DateCreated="2021-04-28">
        <ClinVarSubmissionID localKey="NM_000048.4:c.1045_1057del|MONDO:700092" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001572314" DateUpdated="2023-11-11" DateCreated="2021-04-28" Type="SCV" Version="2" SubmitterName="Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes" OrgID="505613" OrganizationCategory="laboratory" OrgAbbreviation="MedGenet" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000048.4:c.1045_1057del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0700092" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13951935</SubmissionName>
          <SubmissionName>SUB9504954</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1826999" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4641694|MedGen:C0268547" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000933200" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1705937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16941645</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24166829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31943503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16941645</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val349Cysfs*72) in the ASL gene. RNA analysis indicates that this premature translational stop signal induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs762010471, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with argininosuccinate lyase deficiency (PMID: 1705937, 16941645, 24166829). ClinVar contains an entry for this variant (Variation ID: 203629). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects ASL function (PMID: 31943503). Studies have shown that this premature translational stop signal results in skipping of exon 14 (also known as exon 13), but is expected to preserve the integrity of the reading-frame (PMID: 16941645). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.65554663_65554675del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268547" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="441863" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7823169" TraitType="Disease" MappingType="XRef" MappingValue="207900" MappingRef="OMIM">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3418135" TraitType="Disease" MappingType="XRef" MappingValue="C0268547" MappingRef="MedGen">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1543389" TraitType="Disease" MappingType="XRef" MappingValue="207900" MappingRef="OMIM">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1826999" TraitType="Disease" MappingType="XRef" MappingValue="C0268547" MappingRef="MedGen">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3094865" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0700092" MappingRef="MONDO">
        <MedGen CUI="C1535926" Name="Neurodevelopmental disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

